Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.56B | 1.46B | 1.44B | 1.38B | 1.33B |
Gross Profit | 507.09M | 460.30M | 489.11M | 454.66M | 423.78M |
EBITDA | 251.91M | 212.84M | 249.22M | 222.08M | 202.30M |
Net Income | 124.67M | 93.39M | 140.89M | 118.75M | 109.47M |
Balance Sheet | |||||
Total Assets | 2.02B | 2.01B | 1.98B | 1.75B | 1.74B |
Cash, Cash Equivalents and Short-Term Investments | 26.63M | 28.93M | 20.92M | 25.74M | 24.77M |
Total Debt | 633.37M | 658.54M | 650.70M | 511.55M | 527.25M |
Total Liabilities | 962.81M | 961.18M | 982.02M | 807.07M | 806.52M |
Stockholders Equity | 1.06B | 1.05B | 999.60M | 938.42M | 934.34M |
Cash Flow | |||||
Free Cash Flow | 97.94M | 81.83M | -67.25M | 84.43M | 166.62M |
Operating Cash Flow | 157.15M | 169.70M | 12.07M | 145.22M | 218.78M |
Investing Cash Flow | -59.21M | -87.62M | -98.45M | -35.56M | -33.42M |
Financing Cash Flow | -81.55M | -82.00M | 86.18M | -107.76M | -184.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $3.36B | 39.93 | 19.47% | 0.45% | 6.01% | 12.38% | |
70 Outperform | $2.10B | 22.49 | 6.78% | 1.69% | -5.72% | -19.82% | |
70 Neutral | $2.05B | 77.50 | 2.21% | 1.93% | -7.91% | -81.73% | |
69 Neutral | $4.73B | 35.13 | 12.18% | 1.47% | 4.95% | 53.63% | |
57 Neutral | $3.29B | ― | -28.05% | 2.00% | -4.31% | -1421.83% | |
56 Neutral | $19.24B | 83.39 | -6.08% | 2.23% | 0.68% | 66.69% | |
44 Neutral | C$976.69M | -6.88 | -14.61% | 2.56% | 17.52% | -32.77% |
On July 25, 2025, Sensient Technologies reported its financial results for the second quarter ended June 30, 2025. The company saw a 2.7% increase in revenue to $414.2 million compared to the previous year, with operating income rising by 16.2% to $57.7 million. Earnings per share also increased by 20.5% to 88 cents. The Flavors & Extracts Group experienced a revenue decline due to lower volumes in natural ingredients, while the Color Group and Asia Pacific Group saw revenue growth driven by strong performance in food and pharmaceutical lines. The company incurred higher operating expenses primarily due to its Portfolio Optimization Plan.
The most recent analyst rating on (SXT) stock is a Hold with a $95.00 price target. To see the full list of analyst forecasts on Sensient Technologies stock, see the SXT Stock Forecast page.
On June 30, 2025, Sensient Technologies Corporation, through its subsidiary Sensient Receivables LLC, entered into Amendment No. 12 with Wells Fargo Bank to modify their existing Receivables Purchase Agreement. This amendment increases the facility limit from $85 million to $105 million and extends the termination date of the Receivables Securitization Program to August 31, 2026, potentially enhancing the company’s financial flexibility and operational capacity.
The most recent analyst rating on (SXT) stock is a Buy with a $93.00 price target. To see the full list of analyst forecasts on Sensient Technologies stock, see the SXT Stock Forecast page.
On June 13, 2025, Sensient Technologies entered into a Fourth Amended and Restated Credit Agreement, establishing a $400 million senior unsecured revolving credit facility. This agreement, which involves several financial institutions, will be used to refinance existing debt and support general corporate needs, extending the maturity of the credit facility to June 2030. Additionally, Sensient amended a Loan Agreement with PNC Bank to extend its maturity date to June 30, 2027. These financial arrangements are expected to enhance Sensient’s financial flexibility and support its operational and strategic objectives.
The most recent analyst rating on (SXT) stock is a Hold with a $95.00 price target. To see the full list of analyst forecasts on Sensient Technologies stock, see the SXT Stock Forecast page.